Browse the latest headlines and in-depth analysis of Medical Fraud.
By Ruth Anselmi
A federal jury in Boston found Takeda liable for blocking generic competition to its constipation drug Amitiza — the first pay-for-delay antitrust verdict against a pharma company in U.S. class-action history.
By Ruth Anselmi
Four people tied to a Shelton pain clinic face charges over an alleged scheme in which APRM Solutions submitted 4,009 false Medicaid claims for allergy treatments that were never performed or carried out without proper licensing.
By Ruth Anselmi
HHS Inspector General March Bell decertified Hawaii's Medicaid Fraud Control Unit and cut its $3 million annual federal match after finding zero indictments or convictions for Medicaid fraud between 2022 and 2025 — despite $12 million in federal funding over that period.
By Ruth Anselmi
The Justice Department has sued New York state officials and contractor Public Partnerships LLC, alleging a sham bidding process and unauthorized profits in the state's $10 billion Medicaid home-care program.
By Ruth Anselmi
The FDA has issued warning letters to 25 telehealth companies accused of making false and misleading claims about compounded versions of popular weight-loss and diabetes medications.
By Ruth Anselmi
The United States has launched a Section 301 trade investigation into Germany's pharmaceutical pricing policies, escalating tensions over healthcare costs.
By Ruth Anselmi
Ahold Delhaize, owner of Stop & Shop and Giant pharmacies, agreed to a $40 million settlement after allegations that it inflated prescription prices charged to Medicare, Medicaid and TRICARE.
By Ruth Anselmi
Federal authorities arrested Herbert Leon Kimble in the Philippines for allegedly masterminding a $1.2 billion Medicare fraud operation involving unnecessary orthopedic braces.
By Ruth Anselmi
The Ninth Circuit revived a qui tam lawsuit claiming AbbVie and AstraZeneca systematically overcharged public health programs for life-saving drugs.
